BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11059519)

  • 1. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer.
    Kiyohara C
    J Epidemiol; 2000 Sep; 10(5):349-60. PubMed ID: 11059519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
    Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
    Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking.
    Yoshida K; Osawa K; Kasahara M; Miyaishi A; Nakanishi K; Hayamizu S; Osawa Y; Tsutou A; Tabuchi Y; Shimada E; Tanaka K; Yamamoto M; Takahashi J
    Asian Pac J Cancer Prev; 2007; 8(3):438-44. PubMed ID: 18159984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.
    Ma J; Stampfer MJ; Giovannucci E; Artigas C; Hunter DJ; Fuchs C; Willett WC; Selhub J; Hennekens CH; Rozen R
    Cancer Res; 1997 Mar; 57(6):1098-102. PubMed ID: 9067278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans].
    Ozawa S
    Yakugaku Zasshi; 1997 Nov; 117(10-11):895-909. PubMed ID: 9414599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biomarkers of gentotoxic risk and metabolic polymorphism].
    Pavanello S; Clonfero E
    Med Lav; 2000; 91(5):431-69. PubMed ID: 11189784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma.
    Yokoyama A; Kato H; Yokoyama T; Tsujinaka T; Muto M; Omori T; Haneda T; Kumagai Y; Igaki H; Yokoyama M; Watanabe H; Fukuda H; Yoshimizu H
    Carcinogenesis; 2002 Nov; 23(11):1851-9. PubMed ID: 12419833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylenetetrahydrofolate reductase polymorphism and risk of colorectal adenomas.
    Marugame T; Tsuji E; Inoue H; Shinomiya S; Kiyohara C; Onuma K; Hamada H; Koga H; Handa K; Hayabuchi H; Kono S
    Cancer Lett; 2000 Apr; 151(2):181-6. PubMed ID: 10738112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals.
    Nakajima T; Aoyama T
    Ind Health; 2000 Apr; 38(2):143-52. PubMed ID: 10812837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of methylenetetrahydrofolate reductase and aldehyde dehydrogenase 2, alcohol use and risk of colorectal adenomas: Self-Defense Forces Health Study.
    Hirose M; Kono S; Tabata S; Ogawa S; Yamaguchi K; Mineshita M; Hagiwara T; Yin G; Lee KY; Tsuji A; Ikeda N
    Cancer Sci; 2005 Aug; 96(8):513-8. PubMed ID: 16108833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer.
    Katoh T; Kaneko S; Kohshi K; Munaka M; Kitagawa K; Kunugita N; Ikemura K; Kawamoto T
    Int J Cancer; 1999 Nov; 83(5):606-9. PubMed ID: 10521794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome.
    Pande M; Amos CI; Osterwisch DR; Chen J; Lynch PM; Broaddus R; Frazier ML
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2393-401. PubMed ID: 18768509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk.
    Northwood EL; Elliott F; Forman D; Barrett JH; Wilkie MJ; Carey FA; Steele RJ; Wolf R; Bishop T; Smith G
    Pharmacogenet Genomics; 2010 May; 20(5):315-26. PubMed ID: 20375710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP1A1, GSTM1 and GSTT1 genetic polymorphisms and gastric cancer risk among Japanese: A nested case-control study within a large-scale population-based prospective study.
    Hidaka A; Sasazuki S; Matsuo K; Ito H; Charvat H; Sawada N; Shimazu T; Yamaji T; Iwasaki M; Inoue M; Tsugane S;
    Int J Cancer; 2016 Aug; 139(4):759-68. PubMed ID: 27062139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia.
    Rouissi K; Ouerhani S; Hamrita B; Bougatef K; Marrakchi R; Cherif M; Ben Slama MR; Bouzouita M; Chebil M; Ben Ammar Elgaaied A
    Pathol Oncol Res; 2011 Dec; 17(4):879-86. PubMed ID: 21647780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer.
    Chen J; Giovannucci E; Kelsey K; Rimm EB; Stampfer MJ; Colditz GA; Spiegelman D; Willett WC; Hunter DJ
    Cancer Res; 1996 Nov; 56(21):4862-4. PubMed ID: 8895734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
    Daly AK; Cholerton S; Armstrong M; Idle JR
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.